Search Orphan Drug Designations and Approvals
-
Generic Name: | (R)-3-[(4-{1-[1-(3-Carboxy-1-cyclopropyl-7-fluoro-9-methyl-4-oxo-4H-quinolizine-8-yl)-pyrrolidin-3-yl-cyclopropyl]-methylamino}-piperidin-1-ylimino)-methylenyl]-rifamycin |
---|---|
Date Designated: | 01/14/2020 |
Orphan Designation: | Treatment of prosthetic joint infection |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
TenNor Therapeutics Limited 218 Xinghu Street, Building B2, Suite 711 Suzhou Industrial Park Suzhou China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-